Oxidative stress and thyroid hormones in patients with liver diseases

European Journal of Internal Medicine

Volumn 20, Issue 7, 2009, Pages 703-708

  Moustafa, Abdel Halim A ^a   Ali, Ehab M M ^b   Mohamed, Tarek M ^b   Abdou, Heba I ^b  

^a Ain Shams University   (Egypt)

^b Faculty of Science   (Egypt)

Author keywords

Apolipoprotein 1 (APOA1); Glutathione peroxidase (GSHPx); Glutathione reductase (GR); Hepatitis C virus (HCV); Oxidative stress; Thyroid hormones

Indexed keywords

APOLIPOPROTEIN A1; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; LIOTHYRONINE; MALONALDEHYDE; NITRIC OXIDE; THYROID HORMONE; THYROTROPIN; THYROXINE;

ADULT; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LIVER CIRRHOSIS; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; OXIDATIVE STRESS; PROGNOSIS;

ADULT; ALANINE TRANSAMINASE; ANTIOXIDANTS; APOLIPOPROTEIN A-I; ASPARTATE AMINOTRANSFERASES; BIOLOGICAL MARKERS; ERYTHROCYTES; FEMALE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; HEPATITIS C, CHRONIC; HUMANS; HYPERTENSION, PORTAL; LIVER CIRRHOSIS; LIVER DISEASES; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; OXIDATIVE STRESS; THYROID HORMONES; THYROTROPIN; THYROXINE; TRIIODOTHYRONINE;

EID: 70349786534     PISSN: 09536205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejim.2009.08.003     Document Type: Article

References (51)

1. Angulo P. Medical progress: nonalcoholic fatty liver disease. N Engl J Med 346 (2002) 1221-1231
2. Marra F., Gastaldelli A., Baroni G.S., Tell G., and Tiribelli C. Molecular basis and mechanism of progression of non-alcoholic steatohepatitis. Mol Med 14 (2007) 72-81
3. Huang R.H., and Hu K. A practical approach to managing patients with HCV infection. Med Sci 3 (2006) 63-68
4. Fattovich G., Giustina G., Degos F., Tremolada F., Diodati P., Almasio G., et al. Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients. Gastroenterology 112 (1997) 463-472
5. Lauer G.M., and Walker B.D. Hepatitis C virus infection. N Engl J Med 345 (2001) 41-52
6. Bruck R., Shirin H., Aeed H., Matas Z., Hochman A., Pines M., et al. Prevention of hepatic cirrhosis in rats by hydroxyl radical scavengers. Hepatology 35 (2001) 457-464
7. Oztezcan S., Balkan J., Dogru-Abbasoglu S., Cevikbas U., Aykac-Toker G., and Uysal M. Resistance of erythrocytes to lipid peroxidation in cirrhotic rats. Arch Med Res 36 (2005) 459-463
8. Seki S., Kitada T., Yamada T., Sakaguchi H., Nakatani K., and Wakasa K. In situ detection of lipid peroxidation and oxidative DNA damage in non-alcoholic fatty liver diseases. J Hepatol 37 (2002) 56-62
9. Hon W.M., Lee K.H., and Khoo H.E. Nitric oxide in liver diseases: friend, foe, or just passerby?. Ann N Y Acad Sci 962 (2002) 275-283
10. Shah V., Lyford G., Gores G., and Farrugia G. Nitric oxide in gastrointestinal health and disease. Gastroenterology 126 (2004) 903-913
11. Hayes J.D., and McLellan L.I. Glutathione and glutathione-dependent enzymes represent a co-ordinately regulated defence against oxidative stress. Free Radic Res 4 (1999) 273-300
12. Gate L., Paul J., Ba G.N., Tew K.D., and Tapiero H. Oxidative stress induced in pathologies: the role of antioxidants. Biomed Pharamacother 53 (1999) 169-180
13. Rayman M.P. The importance of selenium to human health. Lancet 356 (2000) 233-241
14. Czuczeiko J., Zachara B.A., Staubach-Topczewska E., Halota W., and Kedziora J. Selenium, glutathione and glutathione peroxidase in blood of patients with chronic liver diseases. Acta Biochim Pol 50 (2003) 1147-1154
15. Malik R., and Hodgson H. The relationship between the thyroid gland and the liver. Oxf J Med 59 (2002) 559-563
16. Grant N. The role of triiodothyronine-induced substrate cycles in the hepatic response to overnutrition: thyroid hormone as an antioxidant. Med Hypotheses 68 (2006) 641-649
17. Mancini G., Carbonara A.O., and Heremans J.F. Immunochemical quantitation of antigens by single radial immunodiffusion. Immunochemistry 2 (1965) 235-254
18. Wistom G.B. Enzyme-immunoassay. Clin Chem 22 (1976) 1243-1249
19. M. Uotila, E. Ruoslahti and E. Engvall, Two-site sandwich enzyme immunoassay with monoclonal antibodies to human alpha-fetoprotein. J lmmunol Methods 42: 11-15.
20. Vodovotz Y. Modified microassay for serum nitrite and nitrate. BioTechniques 20 (1996) 390-394
21. Esterbauer H., and Cheeseman K.H. Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal. Methods Enzymol 186 (1990) 407-410
22. Beutler E., Duron O., and Kelly M.B. Improved method for the determination of blood glutathione. J Lab Clin Med 61 (1963) 882-888
23. Paglia E.D., and Valentine W.N. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 70 (1967) 158-169
24. Zanetti G. Rabbit liver glutathione reductase. Purification and properties. Arch Biochem Biophys 198 (1979) 241-246
25. Groszmann R.J. Hyperdynamic circulation of liver disease 40 years later: pathophysiology and clinical consequences. Hepatology 20 (1994) 1359-1363
26. 4 induced acute liver injury of mice. Free Radic Biol Med 29 (2000) 870-880
27. Coskun U., Ozenirler S., Sancak B., and Bukan N. Serum and ascetic fluid nitrate levels in patients with cirrhosis. Clin Chem Acta 306 (2001) 127-132
28. Guarner C., Soriano G., Tomas A., Bulbena O., Novella M.T., Balanzo J., et al. Increased serum nitrite and nitrate levels in patients with cirrhosis: relationship to endotoxemia. Hepatology 18 (1993) 1139-1143
29. Shijo H., Yokoyama M., Ota K., Kokawa H., Kubara K., Kim T., et al. Nitrate kinetics in patients with compensated cirrhosis: correlation with hemodynamics. Am J Gastroenterol 91 (1996) 2190-2194
30. Aksoy H., Korouk M., and AKcay F. The relationship between serum malondialdehyde and ceruloplasmin in chronic liver disease. Turk J Biochem 28 (2003) 32-34
31. Baskol G., Atmaca H., Tanriverdi F., Baskol M., Kocer D., and Bayram F. Oxidative stress and enzymatic antioxidant status in patients with hypothyroidism before and after treatment. Exp Clin Endocrinol Diabetes 115 (2007) 522-526
32. Bianchi G., Bugianesi E., Ronchi M., Fabbri A., Zoli M., and Marcheseini G. Glutathione kinetic in normal man and in patients with liver cirrhosis and hepatocellular carcinoma. Acta Med Croatica 50 (1997) 11-14
33. George J., Pera N., Phung N., Leclercq I., Hou J.Y., and Farrel G. Lipid peroxidation, stellate cell activation and hepatic fibrogenesis in a rat model of chronic steatohepatitis. Hepatology 39 (2003) 756-764
34. Nobili V., Pastore A., Gaetac L.M., Tozzi G., Comparcola D., Sartorellia M.R., et al. Glutathione metabolism and antioxidant enzymes in patients affected by nonalcoholic steatohepatitis. Clin Chem Acta 355 (2005) 105-111
35. Czeczot H., Scibior D., Skrzycki M., and Podsiad M. Glutathione and GSH-dependant enzymes in patients with liver cirrhosis and hepatocellular carcinoma. Acta Biochim Pol 35 (2006) 237-241
36. Das K.S., Balakrishnan V., Mukherjee S., and Vasudevan D.M. Evaluation of blood oxidative stress-related parameters in alcoholic liver disease and non-alcoholic fatty liver disease. Scand J Clin Lab Invest 68 (2008) 323-334
37. Green J.R.B., Snitcher E.J., Mowat N.A.G., Ekins R.P., Rees L.H., and Dawson A.M. Thyroid function and thyroid regulation in euthyroid men with chronic liver disease: evidence of multiple abnormalities. Clin Endocrinol 7 (1977) 453-461
38. Borzio M., Caldara R., Borzio F., Pieopli V., and Rampini P Ferrari C. Thyroid function tests in chronic liver disease: evidence for multiple abnormalities despite clinical euthyroidism. Gut 24 (1983) 631-636
39. Oren R., Sikuler E., Wong F., Blendis L.M., and Halpern Z. The effects of hypothyroidism on liver status of cirrhotic patients. J Clin Gastroenterol 31 (2000) 162-167
40. Antonelli A., Ferri C., Pampana A., Fallahi P., Nesti C., Pasquini M., et al. Thyroid disorders in chronic hepatitis C. Am J Med 117 (2004) 60-64
41. Silveira M.G., Mendes F.D., Diehl N.N., Enders F.T., and Lindor K.D. Thyroid dysfunction in primary biliary cirrhosis, primary sclerosing cholangitis and non-alcoholic fatty liver disease. Liver Int 29 (2009) 1094-1100
42. Yamanaka T., Ido K., Kimura K., and Saito T. Serum levels of thyroid hormones in liver diseases. Clin Chem Acta 101 (1980) 45-55
43. Guven K., Kelestimur F., and Yucesoy M. Thyroid function tests in non-alcoholic cirrhotic patients with hepatic encephalopathy. Eur J Med 2 (1993) 83-87
44. Malik R., and Hodgson H. The relationship between the thyroid gland and the liver. Q J Med (2002) 559-569
45. Taylor A.H., Stephan Z.F., Steele R.E., and Wong N.C. Beneficial effects of a novel thyromimetic on lipoprotein metabolism. Mol Pharmacol 52 (1997) 542-557
46. Ness G.C., and Lopez D. Transcriptional regulation of rat hepatic low-density lipoprotein receptor and cholesterol 7 alpha hydroxylase by thyroid hormone. Arch Biochem 323 (1995) 404-408
47. Nayak S.S., Ramani A., Kamath S.S., Kundaje G.N., and Aroor A.R. Serum apoproteins A and B and the lecithin: cholesterol acyl transferase activities in liver cirrhosis and hepatic coma patients. Biochem Med Metabol Biol India 40 (1988) 299-304
48. Lewis G.F., and Rader D.J. New insights into the regulation of HDL metabolism and reverse cholesterol transport. Circ Res 96 (2005) 1221-1232
49. Katsuramaki T., Hirata K., Kimura Y., Nagayama M., Meguro M., Kimura H., et al. Changes in serum levels of apolipoprotein A-l as an indicator of protein metabolism after hepatectomy. Wound Repair Regen 10 (2002) 77-82
50. Fernandez V., and Videla L. Hepatic glutathione biosynthetic capacity in hyperthyroid rats. Toxicol Lett 16 89 (1996) 85-89
51. Fernandez V., Simizu K., Barros S.B., Azzalis L.A., Pimentel R., Junqueira V.B., et al. Effects of hyperthyroidism on rat liver glutathione metabolism: related enzymes' activities, efflux, and turnover. Endocrinology 129 (1991) 85-91